Despite major advances in targeted therapy, chronic lymphocytic leukemia (CLL) remains largely incurable. Resistance to ...

Concurrent statin therapy was associated with significantly improved survival outcomes and reduced neurotoxicity in patients ...

The Centers for Medicare & Medicaid Services has issued a permanent billing and reimbursement J-code, J9183, for the ...

As treatment options expand in chronic lymphocytic leukemia (CLL), the benefits and limitations of fixed-duration regimens in ...

The investigators note that the lower rate of feeding-tube placement with IMPT at the end of treatment, combined with a ...

The FDA granted fast track designation to PAS-004, a macrocyclic MEK inhibitor, for NF1-associated plexiform neurofibromas ...

According to a recent systematic review published in JCO Oncology Practice, implementation of same-day multidisciplinary ...

The FDA has granted Fast Track Designation to CTIM-76, a claudin-6 (CLDN6) x CD3 T cell engaging bispecific antibody, for the ...

A major pitfall is that most next-generation sequencing assays fail to detect the underlying genetic mechanisms of SMARCB1 ...

Dr Mehra discusses HPV-positive oropharyngeal cancer, focusing on balancing high cure rates while minimizing toxicity through ...

The management of human papillomavirus (HPV)-positive oropharyngeal cancer is shifting as oncologists balance high cure rates ...

Dr Thomas Flaig from the University of Colorado Anschutz discusses a paradigm shift in treating urothelial carcinoma patients ...